Literature DB >> 3729575

Rheumatoid factor in rheumatoid arthritis associated renal disease and in lupus nephritis.

H Helin, M Korpela, J Mustonen, A Pasternack.   

Abstract

To test the hypothesis that rheumatoid factor (RF) protects against (immune complex mediated) renal disease, patients with rheumatoid arthritis (RA; 48 with nephropathy of various types, 35 without renal disease) and systemic lupus erythematosus (SLE; 35 with and 17 without nephritis) were evaluated for the presence and titre of RF. There was no correlation between RF and nephropathy in RA, whereas in SLE RFs were almost exclusively seen in patients without nephropathy. This result supports the above hypothesis for lupus nephropathy but not for RA associated renal disease, and it may be explained by a more pronounced role for immune complexes in SLE and interference of RFs with the complexes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3729575      PMCID: PMC1001924          DOI: 10.1136/ard.45.6.508

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  23 in total

1.  Systemic lupus erythematosus. Morphologic correlations with immunologic and clinical data at the time of biopsy.

Authors:  G S Hill; N Hinglais; F Tron; J F Bach
Journal:  Am J Med       Date:  1978-01       Impact factor: 4.965

2.  Coexistence of systemic lupus erythematosus and rheumatoid arthritis. Report of a case and review of the literature, with clinical, pathologic and serologic observations.

Authors:  G L Kantor; Y B Bickel; E V Barnett
Journal:  Am J Med       Date:  1969-09       Impact factor: 4.965

3.  The immunopathogenesis of lupus nephritis.

Authors:  V Agnello
Journal:  Adv Nephrol Necker Hosp       Date:  1976

4.  The clinical course of the proliferative and membranous forms of lupus nephritis.

Authors:  D S Baldwin; J Lowenstein; N F Rothfield; G Gallo; R T McCluskey
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

5.  Enhancement by IgM rheumatoid factor of in vitro ingestion by macrophages and in vivo clearance of aggregated IgG or antigen-antibody complexes.

Authors:  J L Van Snick; E Van Roost; B Markowetz; C L Cambiaso; P L Masson
Journal:  Eur J Immunol       Date:  1978-04       Impact factor: 5.532

6.  Rheumatoid factor inhibition of in vitro binding of IgG complexes in the human glomerulus.

Authors:  W K Bolton; J H Schrock; J S Davis
Journal:  Arthritis Rheum       Date:  1982-03

7.  Gold nephropathy: tissue analysis by X-ray fluorescent spectroscopy.

Authors:  G W Viol; J A Minielly; T Bistricki
Journal:  Arch Pathol Lab Med       Date:  1977-12       Impact factor: 5.534

8.  Gold-induced immune complex nephritis in seronegative rheumatoid arthritis.

Authors:  B V Skrifvars; T S Törnroth; G N Tallqvist
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

9.  Effect of gold salts and antimalarials on the rheumatoid factor in rheumatoid arthritis.

Authors:  H F Klinefelter; A Achurra
Journal:  Scand J Rheumatol       Date:  1973       Impact factor: 3.641

10.  In vitro demonstration of a particular affinity of glomerular basement membrane and collagen for DNA. A possible basis for a local formation of DNA-anti-DNA complexes in systemic lupus erythematosus.

Authors:  S Izui; P H Lambert; P A Miescher
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

View more
  5 in total

1.  Determination of IgA- and IgM-rheumatoid factors in patients with rheumatoid arthritis with and without nephropathy.

Authors:  M Nakano; M Ueno; S Nishi; S Suzuki; H Hasegawa; T Watanabe; T Kuroda; S Ito; M Arakawa
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

2.  Antibodies to polyclonal IgA, IgA1, and IgA2 and isotype-specific immune complexes in IgA nephropathy.

Authors:  C L Jones; C S Hosking; P Kincaid-Smith; H R Powell; S C Richardson; F H Sennhauser; D M Roberton
Journal:  J Clin Immunol       Date:  1989-07       Impact factor: 8.317

3.  Immunological comparison of patients with rheumatoid arthritis with and without nephropathy.

Authors:  M Korpela; J Mustonen; H Helin; A Pasternack
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

4.  Complement-activating properties of immune complexes are suppressed by IgM rheumatoid factor and enhanced by IgG rheumatoid factor.

Authors:  M Shingu; I Ezaki; M Nobunaga
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

5.  Factors Associated With Renal Involvement in Primary Sjögren's Syndrome: A Meta-Analysis.

Authors:  Ruping Hong; Dong Xu; Evelyn Hsieh; Yirong Xiang; Jiuliang Zhao; Qian Wang; Xinping Tian; Mengtao Li; Yan Zhao; Xiaofeng Zeng
Journal:  Front Med (Lausanne)       Date:  2020-11-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.